Vimarsana
Biggest News Aggregation in the World

Page 17 - Cohort Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cohort Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cohort Study Today - Breaking & Trending Today

RAT test for 'hidden' malaria one step closer to development - Vimarsana News

RAT test for 'hidden' malaria one step closer to development

A simple ‘RAT test’ for hidden malaria developed by Australian scientists might be a true game changer for countries affected by the parasite.

Exercise intensity levels enhance brain power in midlife: study - Vimarsana News

Exercise intensity levels enhance brain power in midlife: study

EXERCISE FOR BRAIN POWER The amount of time spent in moderate and vigorous physical activity in midlife can help enhance brain power, says new research published in the Journal of Epidemiology and Community Health. (Anadolu) LONDON - The amount of time spent in moderate and vigorous physical activity in midlife can help enhance brain power, according to new research published in the Journal of Epidemiology and Community Health. The novel study showed that exercise intensity levels might have an impact on cognitive performance in later life. "Engagement in physical activity (PA) has been l...

'Sitting all day can worsen brain function' - Vimarsana News

'Sitting all day can worsen brain function'

Study also discovers that exercising, as opposed to sitting, improved cognitive function

Source: geo.tv
Special Report on Lung Cancer and Screening Initiatives, Part III - Vimarsana News

Special Report on Lung Cancer and Screening Initiatives, Part III

How the imaging community is working to drive awareness and increase access to life-saving screening

Treatments Help Long-term Outcomes of Critical COVID Illness - Vimarsana News

Treatments Help Long-term Outcomes of Critical COVID Illness

Use of interleukin 6 receptor antagonists and antiplatelet agents was associated with better survival rates and higher quality of life at 6 months.